THE WHAT? Pharmavite has announced that it has acquired Bonafide health for US$425 million. Other commercial terms of the deal were not disclosed. The menopause care firm will expand and complement Pharmavite’s existing women’s health business.

THE DETAILS Bonafide will continue to operate from its current headquarters in Harrison, NY and all employees will be retained.

THE WHY? Jeff Boutelle, CEO of Pharmavite, reveals, “We’re thrilled to welcome Bonafide Health to Pharmavite. This acquisition positions us as the nation’s leading women’s health nutraceutical company, signaling a new era of innovation and science-based solutions in this underserved space. Bonafide’s unwavering commitment to research, development, and robust scientific evidence mirrors Pharmavite’s rigorous standards, while its deep relationship with healthcare professionals aligns with our goal of ensuring nutrition education is at the forefront of the industry.”